Suppressive effects of nitric oxide production and inducible nitric oxide synthase (iNOS) gene expression by Calystegia soldanella methanol extract on lipopolysaccharide-activated RAW 264.7 cells

European Journal of Cancer Prevention

Volumn 13, Issue 5, 2004, Pages 419-424

  Kim, Y ^a   Min, H Y ^a   Park, H J ^a   Lee, E J ^a   Park, E J ^a   Hwang, H J ^a   Jin, C ^b   Lee, Y S ^b   Lee, S K ^a  

^a Ewha Womans University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Calystegia soldanella; Inducible nitric oxide synthase (iNOS); Lipopolysaccharide (LPS); Nitric oxide; RAW 264.7 cells

Indexed keywords

ACTINODAPHNE LANCIFOLIA EXTRACT; CALYSTEGIA SOLDANELLA EXTRACT; CARYRATIA JAPONICA EXTRACT; CITRUS DACHIBANA EXTRACT; DYSTAENIA TAKESHIMANA EXTRACT; ERYSIMUM AURANTIACUM EXTRACT; HOVENIA UNDULATA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; METHANOL DERIVATIVE; NITRIC OXIDE; PLANT EXTRACT; STEWARTIA KOREANA EXTRACT; UNCLASSIFIED DRUG; VIBURNUM AWABUKI EXTRACT;

ACTINODAPHNE LANCIFOLIA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALYSTEGIA; CALYSTEGIA SOLDANELLA; CANCER PREVENTION; CARCINOGENESIS; CARYRATIA JAPONICA; CELL STRAIN; CELL STRAIN RAW 264.7; CITRUS DACHIBANA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DYSTAENIA TAKESHIMANA; ENZYME INHIBITION; ERYSIMUM AURANTIACUM; GENE EXPRESSION; HOVENIA UNDULATA; IC 50; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEWARTIA KOREANA; VIBURNUM AWABUKI;

ANIMALS; CALYSTEGIA; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACTS;

EID: 5044230588     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200410000-00010     Document Type: Article

References (31)

1. Alley MC, Dominic A, Shoemaker RH (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601.
2. 2-expressing human carcinoma cells. Nature Med 4: 1371-1376.
3. Asano N, Yokoyama K, Sakurai M, et al. (2001). Dihydroxynortropane alkaloids from calystegine-producing plants. Phytochemistry 57: 721-726.
4. Chan MM, Hunag HI, Fenton MR, Fong D (1998). In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer chemopreventive natural product with anti-inflammatory properties. Biochem Pharmacol 55: 1955-1962.
5. Gallo O, Masini E, Morbidelli L, et al. (1998). Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596.
6. Caspar EMM (1999). New pentasaccharide macrolactone from the European Convolvulaceae Calystegia soldanella. Tetrahedron Lett 40: 6861-6864.
7. Caspar EMM (2001). Soldanellin B - The first acylated nonlinear tetrasaccharide macrolactone from the European Convolvulaceae Calystegia soldanella. Eur J Org Chem 2001: 369-373.
8. Geller DA, Kussler AK, DiSilvio M, et al. (1993). Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hapatocytes. Proc Natl Acad Sci USA 90: 522-526.
9. 15N]nitrate in biological fluids. Anal Biochem 126: 131-138.
10. Hao XP, Pretlow TG, Rao JS, Pretlow TP (2001). Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res 61: 419-422.
11. Hong CH, Hur SK, Oh OJ, et al. (2002). Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol 83: 153-159.
12. Ippoushi K, Itou H, Azuma K, Higashio H (2002). Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharide-activated macrophages. Life Sci 71: 411-419.
13. G-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 155: 1381-1390.
14. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ (2000). Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60: 184-190.
15. Kageura T, Matsuda H, Morikawa T, et al. (2001). Inhibitors form rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg Med Chem 9: 1887-1893.
16. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP (1999). Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58: 759-765.
17. Kröncke K-D, Fensel K, Kolb-Bachofen V (1998). Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156.
18. Lee Y-N (1996). Flora of Korea. Kyo-Hak Publishing, p. 655.
19. Liang YC, Huang YT, Tsai SH, et al. (1999). Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20: 1945-1952.
20. Lin YL, Lin JK (1997). (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcriptional factor nuclear factor-kappa B. Mol Pharmacol 52: 465-472.
21. Lirk P, Hoffmann G, Rieder J (2002). Inducible nitric oxide synthase? Time for reappraisal. Curr Drug Targets Inflamm Allergy 1: 89-108.
22. Mordan LJ, Burnett TS, Zhang LX, Tom J, Cooney RV (1993). Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H10T1/2 fibroblasts. Carcinogenesis 14: 1555-1559.
23. Nathan C, Xie Q-W (1994). Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728.
24. Ohshima H, Bartsch H (1994). Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253-264.
25. Rao CV, Indranie C, Simi B, et al. (2002). Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62: 165-170.
26. Ryu J-H, Son HJ, Lee SH, Sohn DH (2002). Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-α expression in murine macrophage cell line RAW 264.7. Bioorg Med Chem Lett 12: 649-651.
27. Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA (2002). Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des 8: 177-200.
28. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F (1992). Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 41: 615-624.
29. Song YS, Park EH, Hur GM, et al. (2002). Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett 175: 53-61.
30. Thomsen LL, Miles DW, Happerfield L, et al. (1995). Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-45.
31. Tori M, Ohara Y, Nakashima K, Sono M (2000). Caffeic and coumaric acid esters from Calystegia soldanella. Fitoterapia 71: 353-359.